Piper Sandler analyst Edward Tenthoff maintained a Hold rating on Seres Therapeutics (MCRB – Research Report) today and set a price target of ...

Seres had $30.8 million in cash and cash equivalents. Based on the Company’s current cash, an anticipated second ...

CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Seres Therapeutics (NASDAQ:MCRB – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Tuesday.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are ...

Meghan's forthcoming lifestyle brand, As Ever, replaces American Riviera Orchard, and its logo features some symbolic details – one of which could be a tribute to Prince Harry's late grandmother ...

Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...